Essilorluxottica SA
Essilorluxottica SA designs, produces, and distributes ophthalmic lenses and eyewear, including prescription lenses, sunglasses, and contact lenses, primarily through its retail and wholesale channels.
Business. Essilorluxottica SA (ESLX.PA) is a healthcare services and equipment company operating within the medical equipment, supplies, and distribution industry. The firm generates revenue through the sale of products, with key performance indicators including organic revenue growth, procedure volume, and gross margin. Headquartered in France, the company is primarily listed on the Euronext Paris exchange. Specific details regarding operating segments and geographic revenue mix are not provided.
Analyst recommendations
25 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Essilorluxottica SA (ESLX.PA) is a healthcare services and equipment company operating within the medical equipment, supplies, and distribution industry. The firm generates revenue through the sale of products, with key performance indicators including organic revenue growth, procedure volume, and gross margin. Headquartered in France, the company is primarily listed on the Euronext Paris exchange. Specific details regarding operating segments and geographic revenue mix are not provided.
### Capital Structure and Liquidity Essilorluxottica has a basic and diluted share count of 463,190,305 shares outstanding, indicating no immediate dilution pressure from share-based compensation or convertible instruments. However, liquidity risk could not be assessed due to missing balance-sheet inputs and no going-concern language in source documents.
### Profitability and Returns The company's profitability and return metrics are not available in the current valuation snapshot, precluding a direct comparison to industry_config preferred metrics or cohort medians. Analysts have assigned a mean price target of 300.90 EUR and a median of 310.00 EUR, with a mean recommendation of 1.76, suggesting a generally positive outlook.
### Segments and Geographic Exposure No detailed segment or geographic revenue breakdown is available in the current dataset, limiting the ability to assess revenue concentration or exposure to specific markets.
### Growth Trajectory The company's growth trajectory is not quantified in the current dataset, but the analyst price targets and recommendation scores suggest a generally optimistic view of future performance.
### Risk Factors The primary risk factor is the inability to assess liquidity risk due to missing balance-sheet data. Dilution risk is currently low, with no evidence of dilutive events in the near term.
### Recent Events No recent filings or transcripts are available in the current dataset to inform on recent company developments or strategic shifts.
- Essilorluxottica is a leading player in the medical equipment and supplies industry, with a strong analyst consensus on its future performance.
- The company has no immediate dilution risk, as basic and diluted share counts are equal.
- Analysts have assigned a mean price target of 300.90 EUR and a median of 310.00 EUR, indicating a generally positive outlook.
- Liquidity risk could not be assessed due to missing balance-sheet data, which may limit the ability to evaluate financial stability.
- No recent filings or transcripts are available to provide insight into recent company developments.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Revenue €6.85B.
- ▍Revenue €6.85B
Revenue €6.44B.
- ▍Revenue €6.44B
Revenue €28.49B, +7,5% YoY; Operating income −2,0% YoY.
- ▍Revenue €28.49B, +7,5% YoY
- ▍Operating income −2,0% YoY
- ▍Net income −1,9% YoY
- ▍Free cash flow +19,2% YoY
- ▍Net margin 8.1%
Revenue €26.51B, +4,4% YoY; Operating income +8,6% YoY.
- ▍Revenue €26.51B, +4,4% YoY
- ▍Operating income +8,6% YoY
- ▍Net income +3,1% YoY
- ▍Free cash flow −13,4% YoY
- ▍Net margin 8.9%
Revenue €25.39B, +3,7% YoY; Operating income +0,6% YoY.
- ▍Revenue €25.39B, +3,7% YoY
- ▍Operating income +0,6% YoY
- ▍Net income +6,3% YoY
- ▍Free cash flow +5,6% YoY
- ▍Net margin 9.0%
Revenue €24.49B, +23,6% YoY; Operating income +36,8% YoY.
- ▍Revenue €24.49B, +23,6% YoY
- ▍Operating income +36,8% YoY
- ▍Net income +48,6% YoY
- ▍Free cash flow +12,7% YoY
- ▍Net margin 8.8%
Revenue €19.82B; Operating income €2.31B.
- ▍Revenue €19.82B
- ▍Operating income €2.31B
- ▍Net margin 7.3%
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 7,34 |
| Revenue | —no estimate | —no estimate | 31,1B EUR |
| Operating income | —no estimate | —no estimate | 4,7B EUR |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Essilorluxottica SA Market data — financials · 2026-05-27
- Essilorluxottica SA Market data — analyst estimates · 2026-05-27
Ownership & reference
Leadership
- Francesco MilleriChairman of the Board, Chief Executive Officer